Tag: Novavax

CTK Stock
Business

Novavax, Inc (NASDAQ: NVAX) Has Great Upside Potential

Novavax, Inc (NASDAQ:NVAX) shares, rose in value, with the stock price up by 0.08% to the previous day’s close as strong demand from buyers drove the stock to $6.30. Actively observing the price movement in the recent trading, the stock is buoying the session at

AMMJ Stock
Companies

Novavax, Inc: Making Heads Or Tails Of NVAX Stock

Novavax, Inc (NASDAQ:NVAX) price closed higher on Friday, June 06, and jumping 6.58% above its previous close. A look at the daily price movement shows that the last close reads $6.99. The company’s P/E ratio in the trailing 12-month period read 2.81. Taking into account

Business

Investors: What’s The Real Deal With Novavax, Inc (NASDAQ: NVAX)

The trading price of Novavax, Inc (NASDAQ:NVAX) closed higher on Friday, May 23, and closing at $7.54, 3.94% higher than its previous close. Traders who pay close attention to intraday price movement should know that it fluctuated between $7.25 and $7.595. The company’s P/E ratio

Finance

Novavax, Inc (NVAX) Outlook: Looking Back For Insights

Novavax, Inc (NASDAQ:NVAX) price on Thursday, May 22, rose 2.53% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $7.29. A look at the stock’s price movement, the close in the last trading session was $7.11. The PE

Finance

An Analysis Of Novavax, Inc’s (NVAX) Stock Behavior

Novavax, Inc (NASDAQ:NVAX) concluded the trading at $5.96 on Wednesday, May 14 with a fall of -3.72% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $6.19 and 5Y monthly beta was

Business

Is Novavax, Inc (NASDAQ: NVAX) A Great Stock To Invest In?

Novavax, Inc (NASDAQ:NVAX) traded at $5.97 at close of the session on Friday, May 09 and made a downward move of -10.29% on its previous day’s price. Novavax, Inc has a market cap of $967.77 million and is expected to release its quarterly earnings report

Stocks to Trade

The Reason Behind The Falling Novavax Inc. (NVAX) Stock Price

Shares of US biotech company Novavax at the August 5 aftermarket trading rose 5%, then plunged more than 17% to $204.76 each. The plunge was in response to the upcoming transfer of the application to the United States Food and Drug Administration (FDA) for approval

Stocks Register
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.